BioGaia AB (publ) (FRA:BGLA)
Germany flag Germany · Delayed Price · Currency is EUR
9.34
+0.08 (0.86%)
Last updated: May 13, 2025

BioGaia AB Company Description

BioGaia AB (publ), a healthcare company, provides probiotic products worldwide.

The company operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula and milk formula.

The Adult Health segment provides gut health tablets, bone health tablets and oral health lozenges, as well as cultures, which are used as an ingredient in a licensee’s dairy product.

The Other segment provides packaging solutions. It sells its products through distribution partners or through its own distribution channels.

BioGaia AB (publ) was founded in 1990 and is based in Stockholm, Sweden.

BioGaia AB (publ)
Country Sweden
Founded 1990
Industry Pharmaceutical Preparations
Employees 225
CEO Theresa Agnew

Contact Details

Address:
Kungsbroplan 3
Stockholm, 112 27
Sweden
Phone 46 8 55 52 93 00
Website biogaia.com

Stock Details

Ticker Symbol BGLA
Exchange Frankfurt Stock Exchange
Share Class Class B Shares
Fiscal Year January - December
Reporting Currency SEK
SIC Code 2834

Key Executives

Name Position
Theresa Agnew Chief Executive Officer
Alexander Kotsinas Chief Financial Officer
Ludvig Milesson Chief Operating Officer